<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00055029</url>
  </required_header>
  <id_info>
    <org_study_id>030033</org_study_id>
    <secondary_id>03-EI-0033</secondary_id>
    <nct_id>NCT00055029</nct_id>
  </id_info>
  <brief_title>Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis</brief_title>
  <official_title>X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      This study will explore the causes and eye problems of X-linked juvenile retinoschisis
      (XLRS), an inherited disease that causes vision loss primarily in young males. The vision
      loss, which worsens over time, is a result of schisis, or splitting, of the layers of the
      retina (tissue that lines the back of the eye). A better understanding of why and how XLRS
      develops might lead to improved treatments.

      Patients 9 months of age and older with XLRS and females who are suspected carriers of the
      gene responsible for the disease (such as the mother of the patient) may be eligible for this
      study. Other family members of patients also may be enrolled.

      Patients will undergo the following tests and procedures:

        -  Personal and family medical history to review past and current medical conditions and
           treatments, particularly regarding eye disease, and to construct a family tree.

        -  Eye examination to assess visual acuity (eye chart test) and examine pupils, lens,
           retina, and eye movements. The pupils will be dilated with drops for this examination.

        -  Photography of the retina to help evaluate the status of the retina.

        -  Specialized eye tests to evaluate color vision, field of vision, and ability to see in
           the dark.

        -  Electroretinogram (ERG) to examine what happens to the eyes after a flash of bright
           light. For this test, the patient sits in a dark room for 30 minutes with his or her
           eyes patched. Then, a small silver disk electrode is taped to the forehead, the eye
           patches are removed, the surface of the eye is numbed with eye drops and contact lenses
           are placed on the eyes. The patient looks inside a large empty bowl and then a light
           flashes, first in the dark and then with a light turned on inside the bowl. The contact
           lenses sense small electrical signals generated by the retina when the light flashes.

        -  Blood test to examine DNA for genetic study of XLRS.

      Family members will provide a blood sample for genetic study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:

      The overall goal of this protocol is to better understand the etiology of XLRS disease to
      facilitate further research to identify a potential treatment for the disease. The specific
      primary objectives of this study are to:

        1. Investigate the relationship between genotype and phenotype in X-Linked Retinoschisis by
           correlating four phenotype severity classes with two classes of genotypes (refer to
           Section 7. for definitions). This is the first step in developing a comprehensive
           genotype-phenotype correlation.

        2. Characterize the anatomical and functional characteristics of retinoschisis to refine
           the phenotype scale and investigate and characterize specific XLRS1 mutations to
           generate a well-documented genotype-phenotype correlation map.

      With the opportunity to study the genotypes and phenotypes of many affected males and the
      genotype of family members, a secondary objective of this study will be to develop a detailed
      pedigree for affected families. This information may be used to develop preliminary risk
      estimates for potential carrier females.

      Study Population:

      Up to 500 participants may enroll in this study. A minimum of 150 of participants are
      expected to be males diagnosed with X-Linked Retinoschisis. Participants may be recruited
      from the NIH and also from participating off-site locations. The quality of the genetic
      observation is directly proportional to the number of affected individuals and
      genetically-different families enrolled.

      Design:

      This natural history, multi-center, registry study to enroll males diagnosed with X-Linked
      Retinoschisis and the family members of affected individuals. Onsite affected males will
      undergo clinical examination and have their blood drawn for genotyping. Onsite unaffected
      participants will undergo eye examinations. Blood may also be drawn from the onsite
      unaffected participants but this is not required. Sites outside of NIH are participating as
      referral centers to accumulate the cohort. Offsite affected male participants will forward a
      blood sample and records from previous eye examinations to the NEI for review and analysis.
      Offsite unaffected participants will forward records from previous eye examinations and may
      provide a blood sample although this is not required.

      Outcome Measures:

      The primary outcome is the categorization of the proband s genotype and phenotype and
      determination of the relationship between the two.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 12, 2003</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Retinoschisis</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:

        Eligible participants must satisfy one of the criteria below:

          -  Male diagnosed with X-Linked Juvenile Retinoschisis (proband). A proband will be
             defined as the first X-Linked Juvenile Retinoschisis diagnosed male in a given family
             who contacts the NIH for participation in the study; or

          -  Female who is a suspected carrier (i.e., mother of proband); or

          -  Other relative of proband including affected and unaffected males and females.

        The participant (or the participant s legal guardian) understands and signs this protocol s
        informed consent document and minor participants between the ages of 7 and 17 must provide
        assent.

        EXCLUSION CRITERIA:

        Affected males will be ineligible for participation if:

          -  The participant has a significant media opacity or other obstruction precluding a
             complete fundus examination including retinal photography.

          -  The participant is unwilling or unable to contribute a blood sample for genotyping if
             there is not existing genetic analysis data from a documented family member.

        Both affected and unaffected individuals will be ineligible for participation if:

          -  The participant is younger than two years (seen at the NIH) or younger than nine
             months (participating offsite through medical record review and blood submission).

          -  The participant is unable to cooperate with study procedures without anesthesia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul A Sieving, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Eye Institute (NEI)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy E Turriff</last_name>
    <phone>(301) 402-4175</phone>
    <email>turriffa@mail.nih.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paul A Sieving, M.D.</last_name>
    <phone>(301) 496-2234</phone>
    <email>ps261o@nih.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)</last_name>
      <phone>800-411-1222</phone>
      <phone_ext>TTY8664111010</phone_ext>
      <email>prpl@cc.nih.gov</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2003-EI-0033.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Sieving PA, Bingham EL, Kemp J, Richards J, Hiriyanna K. Juvenile X-linked retinoschisis from XLRS1 Arg213Trp mutation with preservation of the electroretinogram scotopic b-wave. Am J Ophthalmol. 1999 Aug;128(2):179-84.</citation>
    <PMID>10458173</PMID>
  </reference>
  <reference>
    <citation>Eksandh LC, Ponjavic V, Ayyagari R, Bingham EL, Hiriyanna KT, Andr√©asson S, Ehinger B, Sieving PA. Phenotypic expression of juvenile X-linked retinoschisis in Swedish families with different mutations in the XLRS1 gene. Arch Ophthalmol. 2000 Aug;118(8):1098-104.</citation>
    <PMID>10922205</PMID>
  </reference>
  <reference>
    <citation>George ND, Yates JR, Moore AT. X linked retinoschisis. Br J Ophthalmol. 1995 Jul;79(7):697-702. Review.</citation>
    <PMID>7662639</PMID>
  </reference>
  <verification_date>February 5, 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2003</study_first_submitted>
  <study_first_submitted_qc>February 14, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2003</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Retinoschisis</keyword>
  <keyword>Genomic DNA</keyword>
  <keyword>Pedigree Analysis</keyword>
  <keyword>Genetic Analysis</keyword>
  <keyword>Macular Degeneration</keyword>
  <keyword>Juvenile Retinoschisis</keyword>
  <keyword>X-Linked Juvenile Retinoschisis</keyword>
  <keyword>XLRS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinoschisis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

